MLchartDataset catalogue

recombinant super-compound interferon

Term · Oncology and biomedicine · MLC-T-ONC-016458

A recombinant form of the naturally-occurring cytokine interferon-alpha (IFN-a) that has a modified spatial configuration, with immunomodulating, antiviral and antineoplastic activities. Upon administration of recombinant super-compound interferon (rSIFN-co), this agent binds to IFN-specific cell surface receptors, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune-modulating effects. The 3-dimensional conformational change improves efficacy and causes fewer side effects compared to IFN-a.

Table 1. Record
IdentifierMLC-T-ONC-016458
FieldOncology and biomedicine
SynonymsrSIFN-co; recombinant super compound interferon
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016458",
  "term": "recombinant super-compound interferon",
  "field": "Oncology and biomedicine",
  "definition": "A recombinant form of the naturally-occurring cytokine interferon-alpha (IFN-a) that has a modified spatial configuration, with immunomodulating, antiviral and antineoplastic activities. Upon administration of recombinant super-compound interferon (rSIFN-co), this agent binds to IFN-specific cell surface receptors, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune-modulating effects. The 3-dimensional conformational change improves efficacy and causes fewer side effects compared to IFN-a.",
  "synonyms": [
    "rSIFN-co",
    "recombinant super compound interferon"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/recombinant-super-compound-interferon/"
}

Record 14,208 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.